Silencing FOXA1 attenuates invasiveness and proliferation of the highly invasive A549 subpopulations even in conditions without serum starvation [45], suggesting that FOXA1-expressing lung cancer cells have survival advantage or proliferative phenotypes without treatment of serum starvation [45]. The gene discussed is FOXA1; the disease is lung carcinoma.